These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Calmidazolium Chloride and Its Complex with Serum Albumin Prevent Huntingtin Exon1 Aggregation. Singh V; Deepak RNVK; Sengupta B; Joshi AS; Fan H; Sen P; Thakur AK Mol Pharm; 2018 Aug; 15(8):3356-3368. PubMed ID: 29979597 [TBL] [Abstract][Full Text] [Related]
3. The Nt17 Domain and its Helical Conformation Regulate the Aggregation, Cellular Properties and Neurotoxicity of Mutant Huntingtin Exon 1. Vieweg S; Mahul-Mellier AL; Ruggeri FS; Riguet N; DeGuire SM; Chiki A; Cendrowska U; Dietler G; Lashuel HA J Mol Biol; 2021 Oct; 433(21):167222. PubMed ID: 34492254 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of polyglutamine aggregation by SIMILAR huntingtin N-terminal sequences: Prospective molecules for preclinical evaluation in Huntington's disease. Burra G; Thakur AK Biopolymers; 2017 Jul; 108(4):. PubMed ID: 28406522 [TBL] [Abstract][Full Text] [Related]
5. The 17-residue-long N terminus in huntingtin controls stepwise aggregation in solution and on membranes via different mechanisms. Pandey NK; Isas JM; Rawat A; Lee RV; Langen J; Pandey P; Langen R J Biol Chem; 2018 Feb; 293(7):2597-2605. PubMed ID: 29282287 [TBL] [Abstract][Full Text] [Related]
7. Structural insights into the aggregation mechanism of huntingtin exon 1 protein fragment with different polyQ-lengths. Priya SB; Gromiha MM J Cell Biochem; 2019 Jun; 120(6):10519-10529. PubMed ID: 30672003 [TBL] [Abstract][Full Text] [Related]
9. The folding equilibrium of huntingtin exon 1 monomer depends on its polyglutamine tract. Bravo-Arredondo JM; Kegulian NC; Schmidt T; Pandey NK; Situ AJ; Ulmer TS; Langen R J Biol Chem; 2018 Dec; 293(51):19613-19623. PubMed ID: 30315108 [TBL] [Abstract][Full Text] [Related]
10. N-Terminal Fragments of Huntingtin Longer than Residue 170 form Visible Aggregates Independently to Polyglutamine Expansion. Chen MZ; Mok SA; Ormsby AR; Muchowski PJ; Hatters DM J Huntingtons Dis; 2017; 6(1):79-91. PubMed ID: 28339398 [TBL] [Abstract][Full Text] [Related]
11. Arginine is a disease modifier for polyQ disease models that stabilizes polyQ protein conformation. Minakawa EN; Popiel HA; Tada M; Takahashi T; Yamane H; Saitoh Y; Takahashi Y; Ozawa D; Takeda A; Takeuchi T; Okamoto Y; Yamamoto K; Suzuki M; Fujita H; Ito C; Yagihara H; Saito Y; Watase K; Adachi H; Katsuno M; Mochizuki H; Shiraki K; Sobue G; Toda T; Wada K; Onodera O; Nagai Y Brain; 2020 Jun; 143(6):1811-1825. PubMed ID: 32436573 [TBL] [Abstract][Full Text] [Related]
12. Discovery of Small Molecule Inhibitors of Huntingtin Exon 1 Aggregation by FRET-Based High-Throughput Screening in Living Cells. Lo CH; Pandey NK; Lim CK; Ding Z; Tao M; Thomas DD; Langen R; Sachs JN ACS Chem Neurosci; 2020 Aug; 11(15):2286-2295. PubMed ID: 32568514 [TBL] [Abstract][Full Text] [Related]
13. Aggregation landscapes of Huntingtin exon 1 protein fragments and the critical repeat length for the onset of Huntington's disease. Chen M; Wolynes PG Proc Natl Acad Sci U S A; 2017 Apr; 114(17):4406-4411. PubMed ID: 28400517 [TBL] [Abstract][Full Text] [Related]
14. Amplification of neurotoxic HTTex1 assemblies in human neurons. Chongtham A; Isas JM; Pandey NK; Rawat A; Yoo JH; Mastro T; Kennedy MB; Langen R; Khoshnan A Neurobiol Dis; 2021 Nov; 159():105517. PubMed ID: 34563643 [TBL] [Abstract][Full Text] [Related]
15. The dynamics of early-state transcriptional changes and aggregate formation in a Huntington's disease cell model. van Hagen M; Piebes DGE; de Leeuw WC; Vuist IM; van Roon-Mom WMC; Moerland PD; Verschure PJ BMC Genomics; 2017 May; 18(1):373. PubMed ID: 28499347 [TBL] [Abstract][Full Text] [Related]
16. Pathological polyQ expansion does not alter the conformation of the Huntingtin-HAP40 complex. Huang B; Guo Q; Niedermeier ML; Cheng J; Engler T; Maurer M; Pautsch A; Baumeister W; Stengel F; Kochanek S; Fernández-Busnadiego R Structure; 2021 Aug; 29(8):804-809.e5. PubMed ID: 33909994 [TBL] [Abstract][Full Text] [Related]